MoneyWorks4Me

Cipla informs about disclosure

18 Nov 2023 Evaluate

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Cipla has informed that the Company has executed a Facility Demand Guarantee of ZAR 945 million on 17th November, 2023 in favour of First Rand Bank, South Africa (acting though its Rand Merchant Bank division) for extending general banking facilities to Medpro Pharmaceutica, step down wholly owned subsidiary of the Company in South Africa. Details required to be disclosed under the SEBI Listing Regulations, 2015 read with circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated 13th July, 2023 have been provided in Annexure – I to this letter. 

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1760.00
Dr. Reddys Labs. 1231.85
Cipla 1325.00
Lupin 1955.80
Zydus Lifesciences 1124.30
View more..